Results 71 to 80 of about 1,520 (125)

KV7 channel activation inhibits human and murine myometrium contractility and delays delivery in a mouse model of preterm birth

open access: yes
Tribe R   +14 more
europepmc   +1 more source

Fetal and neonatal effects of indomethacin used as a tocolytic agent

American Journal of Obstetrics and Gynecology, 1985
beta-Mimetic agents are currently recommended for tocolysis. Serious adverse reactions including maternal death may complicate their use. Prostaglandin synthetase inhibitors are effective tocolytic agents. Reports of potential adverse effects have limited clinical use in North America.
D K, Dudley, M J, Hardie
exaly   +7 more sources

Prostaglandin inhibitors as tocolytic agents

Seminars in Perinatology, 2001
Indomethacin, a nonspecific prostaglandin synthetase inhibitor, gained popularity several decades ago as a potent tocolytic agent. This popularity, however, was tempered by concerns over fetal and neonatal complications associated with its use. However, with better recognition of the safety limitations, there has been a renewed interest in using ...
Stephen T Vermillion
exaly   +3 more sources

Effect of tocolytic agents on fetal umbilical velocimetry

American Journal of Obstetrics and Gynecology, 1990
In this prospective study, we sought to examine the changes in umbilical vascular resistance induced by tocolytic therapy. Umbilical artery velocimetry was performed in 46 patients with preterm labor before tocolysis and at 1 hour and 24 hours after tocolysis was initiated.
Robert M Patterson
exaly   +3 more sources

Therapeutic Agents in Preterm Labor: Tocolytic Agents

Clinical Obstetrics and Gynecology, 2000
David A Nagey
exaly   +3 more sources

Home - About - Disclaimer - Privacy